GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huakang Biomedical Holdings Co Ltd (HKSE:08622) » Definitions » PS Ratio

Huakang Biomedical Holdings Co (HKSE:08622) PS Ratio : 3.02 (As of Sep. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Huakang Biomedical Holdings Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Huakang Biomedical Holdings Co's share price is HK$0.196. Huakang Biomedical Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.07. Hence, Huakang Biomedical Holdings Co's PS Ratio for today is 3.02.

Warning Sign:

Huakang Biomedical Holdings Co Ltd stock PS Ratio (=5.53) is close to 5-year high of 5.59

The historical rank and industry rank for Huakang Biomedical Holdings Co's PS Ratio or its related term are showing as below:

HKSE:08622' s PS Ratio Range Over the Past 10 Years
Min: 1.29   Med: 2.34   Max: 6.83
Current: 3

During the past 9 years, Huakang Biomedical Holdings Co's highest PS Ratio was 6.83. The lowest was 1.29. And the median was 2.34.

HKSE:08622's PS Ratio is ranked worse than
62.12% of 982 companies
in the Drug Manufacturers industry
Industry Median: 2.235 vs HKSE:08622: 3.00

Huakang Biomedical Holdings Co's Revenue per Sharefor the three months ended in Jun. 2024 was HK$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.07.

Warning Sign:

Huakang Biomedical Holdings Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Huakang Biomedical Holdings Co was -30.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was -6.40% per year.

During the past 9 years, Huakang Biomedical Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 22.60% per year. The lowest was -9.20% per year. And the median was -3.40% per year.

Back to Basics: PS Ratio


Huakang Biomedical Holdings Co PS Ratio Historical Data

The historical data trend for Huakang Biomedical Holdings Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huakang Biomedical Holdings Co PS Ratio Chart

Huakang Biomedical Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only 1.97 1.65 3.10 2.64 1.65

Huakang Biomedical Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 2.82 1.92 1.65 2.88

Competitive Comparison of Huakang Biomedical Holdings Co's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huakang Biomedical Holdings Co's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Huakang Biomedical Holdings Co's PS Ratio falls into.



Huakang Biomedical Holdings Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Huakang Biomedical Holdings Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.196/0.065
=3.02

Huakang Biomedical Holdings Co's Share Price of today is HK$0.196.
Huakang Biomedical Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Huakang Biomedical Holdings Co  (HKSE:08622) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Huakang Biomedical Holdings Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Huakang Biomedical Holdings Co Business Description

Traded in Other Exchanges
N/A
Address
No.16 Yinkui Road, 1-3 floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.
Executives
Arena Investment Management (singapore) Pte Ltd 2102 Investment manager
Arena Investors, Lp 2102 Investment manager
Arena Sg Spv I, Llc 2201 Interest of corporation controlled by you
Tgga, Llc 2106 Person having a security interest in shares
Lau Lai Yee 2201 Interest of corporation controlled by you
Kokusai Resources Company Limited 2101 Beneficial owner
Zhang Shuguang 2101 Beneficial owner
Crystal Grant Limited 2101 Beneficial owner
Chang Yim Yang 2401 A concert party to an agreement to buy shares
Ever Charming Inc. 2101 Beneficial owner
Wealthy Pride Investment Limited 2101 Beneficial owner

Huakang Biomedical Holdings Co Headlines

No Headlines